全文获取类型
收费全文 | 1399篇 |
免费 | 56篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 50篇 |
妇产科学 | 32篇 |
基础医学 | 164篇 |
口腔科学 | 25篇 |
临床医学 | 103篇 |
内科学 | 333篇 |
皮肤病学 | 26篇 |
神经病学 | 104篇 |
特种医学 | 19篇 |
外科学 | 117篇 |
综合类 | 37篇 |
预防医学 | 98篇 |
眼科学 | 41篇 |
药学 | 206篇 |
中国医学 | 15篇 |
肿瘤学 | 69篇 |
出版年
2023年 | 10篇 |
2022年 | 34篇 |
2021年 | 72篇 |
2020年 | 30篇 |
2019年 | 32篇 |
2018年 | 46篇 |
2017年 | 42篇 |
2016年 | 35篇 |
2015年 | 39篇 |
2014年 | 56篇 |
2013年 | 91篇 |
2012年 | 116篇 |
2011年 | 122篇 |
2010年 | 50篇 |
2009年 | 38篇 |
2008年 | 73篇 |
2007年 | 58篇 |
2006年 | 58篇 |
2005年 | 59篇 |
2004年 | 48篇 |
2003年 | 35篇 |
2002年 | 51篇 |
2001年 | 27篇 |
2000年 | 33篇 |
1999年 | 40篇 |
1998年 | 11篇 |
1997年 | 6篇 |
1996年 | 3篇 |
1994年 | 3篇 |
1992年 | 20篇 |
1991年 | 17篇 |
1990年 | 21篇 |
1989年 | 12篇 |
1988年 | 9篇 |
1987年 | 4篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 5篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1977年 | 2篇 |
1975年 | 2篇 |
1974年 | 6篇 |
1972年 | 6篇 |
1970年 | 2篇 |
1969年 | 2篇 |
1968年 | 2篇 |
排序方式: 共有1461条查询结果,搜索用时 0 毫秒
11.
12.
Mounissamy Vassanda Coumar Parihar Raghbendra Singh Dwivedi Anil Kumar Saha Jayanta Kumar Rajendiran Selladurai Lakaria Brij Lal Patra Ashok Kumar 《Bulletin of environmental contamination and toxicology》2021,106(3):536-544
Bulletin of Environmental Contamination and Toxicology - An experiment was conducted to study the effects of co-composted products of municipal solid waste (MSW) and pigeon pea biochar (PPB) on... 相似文献
13.
Abdul Azeez E P G. Anbu Selvi Garima Sharma Senthil Kumar A P 《The International journal of health planning and management》2021,36(1):83-99
The practice of allopathic medicine by informal healthcare practitioners (IHPs) is ubiquitous in India. However, a little is known about the patients' experiences and IHPs' perspectives. The core questions guided the present study were (1) why do urban poor approach IHPs for healthcare? (2) what are their experiences of availing services from IHPs? and (3) what are the perspectives of IHPs about their practice with the population they serve? A qualitative research design guided the study. The study was conducted in the Gurugram city of Haryana, India. Nine IHPs and twenty‐seven patients who fit into the pre‐established inclusion criteria were interviewed. The findings of the study underline the structural constrains of healthcare access to the poor in India and the mutual dependencies between IHPs and the urban poor. Three themes were emerged corresponding to the perspectives of IHPs, and five themes were generated, which describes patients' experiences and perspectives of availing treatment. The factors that attract and sustain patients to IHPs are a mixture of socio‐economic aspects, which include poverty, inaccessibility, unaffordability, inefficient public healthcare facilities, and the positive behavioural and treatment attributes of the practitioners. The study implies urgent policy interventions to ensure quality healthcare to urban poor. 相似文献
14.
Chandradhar Dwivedi Xiangming Guan Wendy L Harmsen Alison L Voss Dawn E Goetz-Parten Erin M Koopman Kelly M Johnson Hima B Valluri Duane P Matthees 《Cancer epidemiology, biomarkers & prevention》2003,12(2):151-156
Studies from our laboratory have indicated skin cancer chemopreventive effectsof sandalwood oil in CD-1 mice. The purpose of this investigation was to study the skin cancer chemopreventive effects of alpha-santalol, a principal component of sandalwood oil in CD-1 and SENCAR mice. alpha-Santalol was isolated from sandalwood oil by distillation under vacuum and characterized by nuclear magnetic resonance and gas chromatography-mass spectrometry. Chemopreventive effects of alpha-santalol were determined during initiation and promotion phase in female CD-1 and SENCAR mice. Carcinogenesis was initiated with 7,12-dimethylbenz(a)anthracene and promoted with 12-O-tetradecanoylphorbol-13-acetate (TPA). The effects of alpha-santalol treatment on TPA-induced epidermal ornithine decarboxylase (ODC) activity and (3)H-thymidine incorporation in epidermal DNA of CD-1 and SENCAR mice were also investigated. alpha-Santalol treatment during promotion phase delayed the papilloma development by 2 weeks in both CD-1 and SENCAR strains of mice. alpha-Santalol treatment during promotion phase significantly (P < 0.05) decreased the papilloma incidence and multiplicity when compared with control and treatment during initiation phase during 20 weeks of promotion in both CD-1 and SENCAR strains of mice. alpha-Santalol treatment resulted in a significant (P < 0.05) inhibition in TPA-induced ODC activity and incorporation of (3)H-thymidine in DNA in the epidermis of both strains of mice. alpha-Santalol significantly prevents papilloma development during promotion phase of 7,12-dimethylbenz(a)anthracene-TPA carcinogenesis protocol in both CD-1 and SENCAR mice, possibly by inhibiting TPA-induced ODC activity and DNA synthesis. alpha-Santalol could be an effective chemopreventive agent for skin cancer. Additional experimental and clinical studies are needed to investigate the chemopreventive effect of alpha-santalol in skin cancer. 相似文献
15.
16.
17.
Prateek Beher John Ashutosh Santoshi Manish Dwivedi Rajkumar Selvanayagam 《中华创伤杂志(英文版)》2021,24(2):113-114
18.
19.
R K Saran K Bhandari V S Narain R C Ahuja V K Puri R Thakur S Dwivedi M Hasan 《International journal of cardiology》1990,28(2):209-213
We report the results of a randomized controlled trial of intravenous streptokinase in a subset of patients with unstable angina. Seventy-six patients were admitted with prolonged (more than 20 minutes) angina at rest of less than 3 weeks onset. Fifty-two patients continued to have more than 3 episodes of prolonged angina in 48 hours on medical therapy with metoprolol, isosorbide dinitrate, nifedipine and intravenous nitroglycerin. Forty-eight patients consented to enter the study and were randomized into two groups. The first group, of 24 patients, received 1.5 million units of streptokinase infusion and the second group, also of 24 patients, received a placebo. Pain relief within 48 hours was achieved in 19/24 (79.1%) patients after streptokinase infusion as compared to 9/24 (37.5%) of the controls (P less than 0.05). Approximately 90% (17/19) of patients responding to streptokinase therapy were relieved of chest pain within the first six hours as against none in the controls. The incidence of acute myocardial infarction within six months was 12.5% (3/24) in those receiving streptokinase and 25% (6/24) in the controls. Mortality at six months stood at 8.33% (2/24) in the treated patients and 16.6% (4/24) in the controls. Intravenous streptokinase thus appears to be of benefit in patients with angina at rest of recent onset which does not respond to conventional medical therapy. 相似文献
20.